OV888

N/A

Report date: 2024/05/30 09:24:40
NME

Base Information

Drug NameOV888
Drug Alias NameOV-888OV888GV-101GV 101GV101
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionRho-associated protein kinase 2 inhibitors
TargetsRho-associated protein kinase 2
Therapy Area/IndicationsBody WeightHemangioma, Cavernous, Central Nervous System
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesIsrael
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesGraviton Bioscience Corp
China Registration ClassN/A

Develop Information

Active CompaniesOvid Therapeutics IncGraviton Bioscience Corp
Inactive CompaniesN/A
Active IndicationsBody WeightHemangioma, Cavernous, Central Nervous System
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A